Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19011757 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL803397 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL19011892 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL15391925 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL15391171 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL804256 | 1.00 | THRB (0.32) | THRBLMNA | |
| SCHEMBL17445737 | 0.85 | THRB (0.59) | THRBLMNA | |
| SCHEMBL17437708 | 0.85 | THRB (0.59) | THRBLMNA | |
| SCHEMBL15696572 | 0.85 | — | — | |
| SCHEMBL18837974 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017105985-A1 | PREPARATION OF ISOHEXIDE-3,6-DICARBALDEHYDES AND ISOHEXIDE-3,6-DIMETHANAMINES | ARCHER DANIELS MIDLAND COMPANY (US) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017105985-A1 | PREPARATION OF ISOHEXIDE-3,6-DICARBALDEHYDES AND ISOHEXIDE-3,6-DIMETHANAMINES | ARCHER DANIELS MIDLAND COMPANY (US) | 2017-06-22 | — | — | WO | disclosed |
| WO-2013173020-A1 | ISOSORBIDE AND ISOMANNIDE DERIVATIVES AND PROCESSES FOR MAKING THE SAME | ARCHER DANIELS MIDLAND COMPANY (US) | 2013-11-21 | — | — | WO | disclosed |
| US-20120071577-A1 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS | EVONIK DEGUSSA GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071577-A1 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS | G6PD, DERA, MPI | THRB 4698/4885LMNA 2634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.